EUVIMEDEUVIMED entdecken
Crossref

Programmable Singlet Oxygen Battery for Automated Photodynamic Therapy Enabled by Pyridone–Pyridine Tautomer Engineering

Jianwu Tian, Bowen Li, Chongzhi Wu, Zhiyao Li, Honglin Tang, Wentao Song, Guo-Bin Qi, Yufu Tang, Yuan Ping iD, Bin Liu iD

Journal of the American Chemical Society · 19.06.2024 · 146 (24) · 16458-16468

DOI: 10.1021/jacs.4c02500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 16.05.2024. Verfasst von Jianwu Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 1, Singapore 117585, Singapore. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National University of Singapore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of photodynamic therapy is hindered by the hypoxic environment in tumors and limited light penetration depth. The singlet oxygen battery (SOB) has emerged as a promising solution, enabling oxygen- and light-independent 1O2 release. However, conventional SOB systems typically exhibit an "always-ON" 1O2 release, leading to potential 1O2 leakage before and after treatment. This not only compromises therapeutic outcomes but also raises substantial biosafety concerns. In this work, we introduce a programmable singlet oxygen battery, engineered to address all the issues discussed above. The concept is illustrated through the development of a tumor-microenvironment-responsive pyridone-pyridine switch, PyAce, which exists in two tautomeric forms: PyAce-0 (pyridine) and PyAce (pyridone) with different 1O2 storage half-lives. In its native state, PyAce remains in the pyridone form, capable of storing 1O2 (t1/2 = 18.5 h). Upon reaching the tumor microenvironment, PyAce is switched to the pyridine form, facilitating rapid and thorough 1O2 release (t1/2 = 16 min), followed by quenched 1O2 release post-therapy. This mechanism ensures suppressed 1O2 production pre- and post-therapy with selective and rapid 1O2 release at the tumor site, maximizing therapeutic efficacy while minimizing side effects. The achieved "OFF-ON-OFF" 1O2 therapy showed high spatiotemporal selectivity and was independent of the oxygen supply and light illumination.

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 1, Singapore 117585, Singapore.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Yuan Ping, Bin Liu

Förderung

  • National University of Singapore

Zitieren

APA

Tian, J., Li, B., Wu, C., Li, Z., Tang, H., Song, W., Qi, G. B., Tang, Y., Ping, Y., & Liu, B. (2024). Programmable Singlet Oxygen Battery for Automated Photodynamic Therapy Enabled by Pyridone–Pyridine Tautomer Engineering. Journal of the American Chemical Society, 146(24), 16458-16468. https://doi.org/10.1021/jacs.4c02500

Vancouver

Tian J, Li B, Wu C, Li Z, Tang H, Song W, et al. Programmable Singlet Oxygen Battery for Automated Photodynamic Therapy Enabled by Pyridone–Pyridine Tautomer Engineering. Journal of the American Chemical Society. 2024;146(24):16458-16468. doi:10.1021/jacs.4c02500

BibTeX
@article{Tian2024,
  author = {Tian, Jianwu and Li, Bowen and Wu, Chongzhi and Li, Zhiyao and Tang, Honglin and Song, Wentao and Qi, Guo-Bin and Tang, Yufu and Ping, Yuan and Liu, Bin},
  title = {Programmable Singlet Oxygen Battery for Automated Photodynamic Therapy Enabled by Pyridone–Pyridine Tautomer Engineering},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {24},
  pages = {16458--16468},
  doi = {10.1021/jacs.4c02500}
}
Kostenlos starten →